Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Nocion Therapeutics, Inc.

News headline image
Nocion Therapeutics to Present Preclinical Data Supporting Nocions™ as a Novel Approach for the Treatment of Pain at the Non-Opioid Pain Therapeutics Summit
From Nocion Therapeutics, Inc.
Via Business Wire
News headline image
Nocion Therapeutics Extends Series B Financing to $93 Million to Support Late-Stage Development of Taplucainium in Chronic Cough
From Nocion Therapeutics, Inc.
Via Business Wire
News headline image
Nocion Therapeutics Appoints Matthew Frankel, M.D., MBA to Chief Medical Officer
From Nocion Therapeutics, Inc.
Via Business Wire
News headline image
Nocion Therapeutics Announces First Patient Dosed in ASPIRE Phase 2b Chronic Cough Study
From Nocion Therapeutics, Inc.
Via Business Wire
News headline image
Nocion Therapeutics Presents Data on Preclinical and Clinical Development of Taplucainium, a Novel, Charged Sodium Channel Blocker, as a potential treatment for Chronic Cough at the 13th London International Cough Symposium
From Nocion Therapeutics, Inc.
Via Business Wire
News headline image
Nocion Therapeutics Appoints Dr. Catherine Bonuccelli to Scientific Advisory Board and Joan Shaw to Senior Vice President, Clinical Operations
From Nocion Therapeutics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.